z-logo
open-access-imgOpen Access
miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4
Author(s) -
Furong Nie,
Q X Li,
Hongfa Wei,
Yaqi Ma
Publication year - 2020
Publication title -
neoplasma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2020_190731n696
Subject(s) - cancer research , carcinogenesis , vimentin , erbb3 , microrna , thyroid carcinoma , epidermal growth factor receptor , downregulation and upregulation , cell growth , gene knockdown , tumor progression , cancer , biology , chemistry , cell culture , pathology , medicine , thyroid , endocrinology , immunohistochemistry , gene , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here